Salicylates: Molecular Mechanism of Therapeutic Action
- 1 January 1980
- book chapter
- Published by Elsevier
- Vol. 17, 233-288
- https://doi.org/10.1016/s1054-3589(08)60012-5
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Chemotactic factor‐induced generation of superoxide radicals by human neutrophilsArthritis & Rheumatism, 1979
- Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandinBiochemical and Biophysical Research Communications, 1977
- Enkephalin pentapeptides — A review of current evidence for a physiological role in vertebrate neurotransmissionLife Sciences, 1977
- Antiplatelet drugs — A new pharmacologic approach to the prevention of thrombosisAmerican Heart Journal, 1976
- Prostaglandin endoperoxides IV. Effects on smooth muscleLife Sciences, 1975
- Inhibitory effects of aspirin and indomethacin on the biosynthesis of PGE2 and PGF2αBiochemical and Biophysical Research Communications, 1974
- The effects of some salicylate analogues on human blood platelets: 2. The role of platelet acetylation in the inhibition of platelet aggregationLife Sciences, 1974
- Inhibition of prostaglandin synthesis in manBiochemical and Biophysical Research Communications, 1972
- Relationship between inhibition of prostaglandin synthesis and drug efficacy: Support for the current theory on mode of action of aspirin-like drugsBiochemical and Biophysical Research Communications, 1972
- The effect of sodium salicylate on the ATP-level in normal and inflamed tissueLife Sciences, 1967